Pharmaceuticals Global Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025

Pharmaceuticals Global Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative Summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
- All market data and forecasts are represented in nominal terms (i.e., without adjustment for inflation) and all currency conversions used in the creation of this report have been calculated using constant 2020 annual average exchange rates.
- Forecast figures presented in this report are calculated using crisis scenarios for the market. The length of the pandemic and restrictions introduced by various countries are still difficult to predict. Many governments had introduced the national lockdowns and temporarily banned sales of products that are deemed "non-essential". As the length of the pandemic and its impact on this market is not certain, the data used in this report has been modeled taking forecast impacts on national economics into consideration.
- The global pharmaceuticals market had total revenues of $1,112.6bn in 2020, representing a compound annual growth rate (CAGR) of 5.6% between 2016 and 2020.
- Given the strong global demand for vaccines to protect citizens and control the spread of COVID-19, it is likely that pharmaceutical companies offering safe and effective therapeutic solutions will generate significant revenues, contributing to market growth.
- The promotion of generic drugs has become increasingly prevalent globally as many governments seek to generate savings amid rising pharmaceutical prices, and this presents a barrier to growth in the market.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to Buy

- What was the size of the global pharmaceuticals market by value in 2020?
- What will be the size of the global pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the global pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the global pharmaceuticals market?

1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Competitive Landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Pharmaceuticals
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Pharmaceuticals in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Pharmaceuticals in France
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
8 Pharmaceuticals in Germany
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators
9 Pharmaceuticals in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators
10 Pharmaceuticals in Japan
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators
11 Pharmaceuticals in Australia
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
11.6. Macroeconomic Indicators
12 Pharmaceuticals in Canada
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
12.6. Macroeconomic Indicators
13 Pharmaceuticals in China
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis
13.6. Macroeconomic Indicators
14 Pharmaceuticals in The Netherlands
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
14.6. Macroeconomic Indicators
15 Pharmaceuticals in Spain
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis
15.6. Macroeconomic Indicators
16 Pharmaceuticals in The United Kingdom
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
16.6. Macroeconomic Indicators
17 Pharmaceuticals in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis
17.6. Macroeconomic Indicators
18 Company Profiles
18.1. Sanofi SA
18.2. Laboratoires Pierre Fabre SA
18.3. Les Laboratoires Servier
18.4. F. Hoffmann-La Roche Ltd
18.5. Bayer AG
18.6. Boehringer Ingelheim GmbH
18.7. Menarini Industrie Farmaceutiche Riunite Srl
18.8. Recordati S.p.A.
18.9. Chiesi Farmaceutici SpA
18.10. Daiichi Sankyo Co Ltd
18.11. Astellas Pharma Inc.
18.12. Takeda Pharmaceutical Company Limited
18.13. Mitsubishi Tanabe Pharma Corporation
18.14. Aspen Pharmacare Holdings Ltd
18.15. Apotex, Inc.
18.16. Yangtze River Pharmaceutical Group
18.17. Shanghai Pharmaceuticals Holding Co Ltd
18.18. Yunnan Baiyao Group Co Ltd
18.19. Guangzhou Pharmaceutical Holdings Ltd
18.20. Almirall S.A.
18.21. Laboratorios Farmaceuticos ROVI, S.A.
18.22. Novartis AG
18.23. GlaxoSmithKline Plc
18.24. Johnson & Johnson
18.25. Pfizer Inc.
18.26. Merck & Co., Inc.
18.27. AstraZeneca PLC
19 Appendix
19.1. Methodology
19.2. About MarketLine

List Of Tables


Table 1: Global pharmaceuticals market value: $ billion, 2016-20
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Global pharmaceuticals market share: % share, by value, 2020
Table 4: Global pharmaceuticals market value forecast: $ billion, 2020-25
Table 5: Global size of population (million), 2016-20
Table 6: Global gdp (constant 2005 prices, $ billion), 2016-20
Table 7: Global gdp (current prices, $ billion), 2016-20
Table 8: Global inflation, 2016-20
Table 9: Global consumer price index (absolute), 2016-20
Table 10: Global exchange rate, 2016-20
Table 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20
Table 12: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2020
Table 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2020
Table 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25
Table 15: Europe pharmaceuticals market value: $ billion, 2016-20
Table 16: Europe pharmaceuticals market geography segmentation: $ billion, 2020
Table 17: Europe pharmaceuticals market share: % share, by value, 2020
Table 18: Europe pharmaceuticals market value forecast: $ billion, 2020-25
Table 19: Europe size of population (million), 2016-20
Table 20: Europe gdp (constant 2005 prices, $ billion), 2016-20
Table 21: Europe gdp (current prices, $ billion), 2016-20
Table 22: Europe inflation, 2016-20
Table 23: Europe consumer price index (absolute), 2016-20
Table 24: Europe exchange rate, 2016-20
Table 25: France pharmaceuticals market value: $ billion, 2016-20
Table 26: France pharmaceuticals market geography segmentation: $ billion, 2020
Table 27: France pharmaceuticals market share: % share, by value, 2020
Table 28: France pharmaceuticals market value forecast: $ billion, 2020-25
Table 29: France size of population (million), 2016-20
Table 30: France gdp (constant 2005 prices, $ billion), 2016-20
Table 31: France gdp (current prices, $ billion), 2016-20
Table 32: France inflation, 2016-20
Table 33: France consumer price index (absolute), 2016-20
Table 34: France exchange rate, 2016-20
Table 35: Germany pharmaceuticals market value: $ billion, 2016-20
Table 36: Germany pharmaceuticals market geography segmentation: $ billion, 2020
Table 37: Germany pharmaceuticals market share: % share, by value, 2020
Table 38: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Table 39: Germany size of population (million), 2016-20
Table 40: Germany gdp (constant 2005 prices, $ billion), 2016-20
Table 41: Germany gdp (current prices, $ billion), 2016-20
Table 42: Germany inflation, 2016-20
Table 43: Germany consumer price index (absolute), 2016-20
Table 44: Germany exchange rate, 2016-20
Table 45: Italy pharmaceuticals market value: $ billion, 2016-20
Table 46: Italy pharmaceuticals market geography segmentation: $ billion, 2020
Table 47: Italy pharmaceuticals market share: % share, by value, 2020
Table 48: Italy pharmaceuticals market value forecast: $ billion, 2020-25
Table 49: Italy size of population (million), 2016-20
Table 50: Italy gdp (constant 2005 prices, $ billion), 2016-20
Table 51: Italy gdp (current prices, $ billion), 2016-20
Table 52: Italy inflation, 2016-20
Table 53: Italy consumer price index (absolute), 2016-20
Table 54: Italy exchange rate, 2016-20
Table 55: Japan pharmaceuticals market value: $ billion, 2016-20
Table 56: Japan pharmaceuticals market geography segmentation: $ billion, 2020
Table 57: Japan pharmaceuticals market share: % share, by value, 2020
Table 58: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Table 59: Japan size of population (million), 2016-20
Table 60: Japan gdp (constant 2005 prices, $ billion), 2016-20
Table 61: Japan gdp (current prices, $ billion), 2016-20
Table 62: Japan inflation, 2016-20
Table 63: Japan consumer price index (absolute), 2016-20
Table 64: Japan exchange rate, 2016-20
Table 65: Australia pharmaceuticals market value: $ billion, 2016-20
Table 66: Australia pharmaceuticals market geography segmentation: $ billion, 2020
Table 67: Australia pharmaceuticals market share: % share, by value, 2020
Table 68: Australia pharmaceuticals market value forecast: $ billion, 2020-25
Table 69: Australia size of population (million), 2016-20
Table 70: Australia gdp (constant 2005 prices, $ billion), 2016-20

List Of Figures


Figure 1: Global pharmaceuticals market value: $ billion, 2016-20
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Global pharmaceuticals market share: % share, by value, 2020
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the global pharmaceuticals market, 2020
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2020
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2020
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2020
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2020
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2020
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2016-20
Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2020
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2020-25
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2020
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2020
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2020
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2020
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2020
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2020
Figure 21: Europe pharmaceuticals market value: $ billion, 2016-20
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 23: Europe pharmaceuticals market share: % share, by value, 2020
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2020-25
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2020
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2020
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2020
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2020
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2020
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2020
Figure 31: France pharmaceuticals market value: $ billion, 2016-20
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 33: France pharmaceuticals market share: % share, by value, 2020
Figure 34: France pharmaceuticals market value forecast: $ billion, 2020-25
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2020
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2020
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2020
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2020
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2020
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2020
Figure 41: Germany pharmaceuticals market value: $ billion, 2016-20
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 43: Germany pharmaceuticals market share: % share, by value, 2020
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2020
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2020
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2020
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2020
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2020
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2020
Figure 51: Italy pharmaceuticals market value: $ billion, 2016-20
Figure 52: Italy pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 53: Italy pharmaceuticals market share: % share, by value, 2020
Figure 54: Italy pharmaceuticals market value forecast: $ billion, 2020-25
Figure 55: Forces driving competition in the pharmaceuticals market in Italy, 2020
Figure 56: Drivers of buyer power in the pharmaceuticals market in Italy, 2020
Figure 57: Drivers of supplier power in the pharmaceuticals market in Italy, 2020
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2020
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2020
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2020
Figure 61: Japan pharmaceuticals market value: $ billion, 2016-20
Figure 62: Japan pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 63: Japan pharmaceuticals market share: % share, by value, 2020
Figure 64: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Figure 65: Forces driving competition in the pharmaceuticals market in Japan, 2020
Figure 66: Drivers of buyer power in the pharmaceuticals market in Japan, 2020
Figure 67: Drivers of supplier power in the pharmaceuticals market in Japan, 2020

2022 Valeant Pharmaceuticals Half-Year Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 850 View Report

2022 Teva Pharmaceuticals Half-Year Review and Outlook--Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 850 View Report

Games Software Retail Global Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025

Games Software Retail Global Industry Guide - Market , Competitive Analysis and Forecast to 2025Global Games Software industry profile provides top-line qualitative and quantitative information including: market size (value

USD 1495 View Report

Apparel Retail Global Industry Almanac - Market Summary, Competitive Analysis and Forecast to 2025

Apparel Retail Global Industry Almanac - Market , Competitive Analysis and Forecast to 2025Global Apparel Retail industry profile provides top-line qualitative and quantitative information including: industry size (value 2016-20,

USD 2995 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available

 

 

FAQs

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.